Literature DB >> 17548638

Macrophage-inflammatory protein-3alpha mediates epidermal growth factor receptor transactivation and ERK1/2 MAPK signaling in Caco-2 colonic epithelial cells via metalloproteinase-dependent release of amphiregulin.

Sarah Keates1, Xinbing Han, Ciarán P Kelly, Andrew C Keates.   

Abstract

Previously, we reported that normal colonocytes produce the memory CD4(+) T cell-directed chemokine MIP-3alpha, and that epithelial MIP-3alpha levels are elevated in inflammatory bowel disease. Interestingly, the unique receptor for MIP-3alpha, CCR6, is expressed by a variety of cell types including colonocytes, suggesting that MIP-3alpha may regulate additional biological activities in the intestine. The aim of this study was to determine whether MIP-3alpha can induce intestinal epithelial cell proliferation and to examine the signaling mechanisms that mediate this response. We show that nonstimulated Caco-2 and HT-29 colonic epithelial cells express CCR6, and that stimulation of Caco-2 cells by MIP-3alpha can dose dependently increase cell proliferation as well as activate the epidermal growth factor receptor (EGFR) and ERK1/2 MAPK. MIP-3alpha-mediated ERK1/2 activation in Caco-2 cells appeared to require metalloproteinase-dependent release of the endogenous EGFR ligand amphiregulin and transactivation of the EGFR. Moreover, blockade of amphiregulin bioactivity using a neutralizing polyclonal Ab significantly reduced MIP-3alpha-mediated, but not EGF-mediated Caco-2 cell proliferation. Taken together, our findings indicate that MIP-3alpha can regulate mitogenic signaling in colonic epithelial cells and thus may serve an important homeostatic function in the intestine by regulating tissue turnover and maintenance of the epithelium, in addition to its role in regulating leukocyte recruitment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548638     DOI: 10.4049/jimmunol.178.12.8013

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation.

Authors:  Fan Zhang; Hua Yang; Zan Pan; Zheng Wang; J Mario Wolosin; Per Gjorstrup; Peter S Reinach
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

2.  Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution.

Authors:  Sara L Svensson; Mukesh Pasupuleti; Björn Walse; Martin Malmsten; Matthias Mörgelin; Camilla Sjögren; Anders I Olin; Mattias Collin; Artur Schmidtchen; Ruth Palmer; Arne Egesten
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

Review 3.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

Review 4.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

5.  Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages.

Authors:  Bisweswar Nandi; Mia Shapiro; Mehmet K Samur; Christine Pai; Natasha Y Frank; Charles Yoon; Rao H Prabhala; Nikhil C Munshi; Jason S Gold
Journal:  Oncoimmunology       Date:  2016-05-24       Impact factor: 8.110

6.  The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndrome.

Authors:  Margherita Sisto; Sabrina Lisi; Massimo D'Amore; Dario Domenico Lofrumento
Journal:  Clin Exp Med       Date:  2014-03-25       Impact factor: 3.984

7.  Functional microarray analysis suggests repressed cell-cell signaling and cell survival-related modules inhibit progression of head and neck squamous cell carcinoma.

Authors:  Anna E L Coló; Ana C Q Simoes; André L Carvalho; Camila M Melo; Lucas Fahham; Luiz P Kowalski; Fernando A Soares; Eduardo J Neves; Luiz F L Reis; Alex F Carvalho
Journal:  BMC Med Genomics       Date:  2011-04-13       Impact factor: 3.063

8.  miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease.

Authors:  Xiuqin Cheng; Xiaofei Zhang; Jiewen Su; Yingdi Zhang; Weimei Zhou; Jun Zhou; Cheng Wang; Hongwei Liang; Xi Chen; Ruihua Shi; Ke Zen; Chen-Yu Zhang; Hongjie Zhang
Journal:  Sci Rep       Date:  2015-05-22       Impact factor: 4.379

9.  CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.

Authors:  Bisweswar Nandi; Christine Pai; Qin Huang; Rao H Prabhala; Nikhil C Munshi; Jason S Gold
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

10.  Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin.

Authors:  Emily F A van 't Wout; Jennifer A Dickens; Annemarie van Schadewijk; Imran Haq; Hang Fai Kwok; Adriana Ordóñez; Gillian Murphy; Jan Stolk; David A Lomas; Pieter S Hiemstra; Stefan J Marciniak
Journal:  Hum Mol Genet       Date:  2013-10-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.